NIBP (Non-invasive Blood Pressure) Algorithm Enhancements (Characterize the Robustness of Motion Artifact Suppression)

Movement, Involuntary Clinical Trial

Official title:
NIBP Algorithm Enhancements - MA_PM_NIBP Algorithm Enhancements_2021_11266

Status Terminated

Clinical Trial Summary

The study intervention consists of a non-invasive blood pressure (NIBP) measurement device and cuff (FDA-cleared Philips IntelliVue X3 Rev. N.04 patient monitor) running a non-approved modified software containing an enhanced measurement algorithm for NIBP.

Clinical Trial Description

The purpose of this study is to compare measurements of NIBP taken by the study device and measurements taken by the current FDA-approved algorithm included in Rev. N.0 software for the IntelliVue patient monitors during motion artifact in patients undergoing caesarian section deliveries under epidural anesthesia. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05185037
Study type	Observational
Source	Philips Clinical & Medical Affairs Global
Contact
Status	Terminated
Phase
Start date	May 26, 2022
Completion date	November 16, 2023

View Details

See also
	Status	Clinical Trial	Phase
	Not yet recruiting	`NCT04615598` - Assessment of the Effects of Mental Practice on Tongue Strength in Brain-damaged Patients	N/A
	Not yet recruiting	`NCT04548336` - Mental Practice on Balance	N/A